Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Germany
- United Kingdom
- France
- Portugal
- Sweden
- Spain
- Italy
- Netherlands
- Belgium
- Poland
- Denmark
- Norway
- Canada
- Czech
- United Arab Emirates
- Singapore
- Austria
- Australia
- Finland
- Hong Kong
- Ireland
- Switzerland
- Romania
- Croatia
- Luxembourg
- China
- Lithuania
- Japan
- Brazil
- Cyprus
- Morocco
- Greece
- Saudi Arabia
- Estonia
- Mexico
- New Zealand
- India
- Latvia
- Macau
- Slovakia
- Andorra
- Bulgaria
- Europe
- Iceland
- Malta
- Worldwide
- Czech Republic
- South Africa
- South Korea
- Taiwan
- Ukraine
- 42 more »
- « less
-
Program
-
Field
- Medical Sciences
- Biology
- Computer Science
- Economics
- Engineering
- Business
- Science
- Chemistry
- Education
- Mathematics
- Materials Science
- Psychology
- Arts and Literature
- Social Sciences
- Law
- Humanities
- Linguistics
- Environment
- Sports and Recreation
- Earth Sciences
- Philosophy
- Electrical Engineering
- Physics
- Design
- 14 more »
- « less
-
University More Jobs from This Employer https://main.hercjobs.org/jobs/22131344/part-time-lecturer-immunology-cell-gene-therapy-ms-program Return to Search Results
-
individuals, biochemical markers, cognitive testing, animal models, and cell biology experiments. Our long-term goal is to contribute to the development of new treatments for neurodegenerative diseases, where
-
challenges. Generous donors to the University are driving social mobility through scholarships and hardship funding, supporting research into devastating diseases and helping tackle issues like climate change
-
: segreteria.perugia@ibbr.cnr.it Contact phone: +39 075 5014811 Annual budget: 29604,84 Frequency of calls: 12 International mobility required: no Website for additional job details http://www.urp.cnr.it Work Location(s
-
with therapeutic response and resistance to RAS inhibition in non-small cell lung cancer (NSCLC) in the laboratory of Ferdinandos Skoulidis, MD, PhD, at the University of Texas MD Anderson Cancer Center
-
the cellular and molecular heterogeneity of various TMEs with highest sensitivity down to the singlecell level to define how they regulate cell and tissue functions under physiological and pathological
-
for the implementation, validation, and development of in vivo models to study the efficacy and safety of CAR-T cell therapy. You will be a key team member and expert responsible for the creation and execution of the in
-
Investigating the role of Ect2 in pancreatic cancer cell proliferation and motility School of Biosciences PhD Research Project Self Funded Dr Helen Matthews Application Deadline: Applications
-
at Karolinska Institutet and SciLifeLab, Stockholm, Sweden. Our research focuses on elucidating the molecular mechanisms underlying cell division and chromatin organization in mouse and human cells. We employ
-
of SPPL3 (Hobohm et al. (2022), Cell Mol Life Sci; Truberg et al. (2022), BBA Mol Cell Res; Brauer et al. (2024), EMBO J). Moreover, many independent studies have confirmed SPPL3 as a potent regulator of